[The future of subjects of surgery of urogenital tuberculosis].
D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D003556:Cystitis / Q000209:etiology*; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis; D014401:Tuberculosis, Urogenital / Q000601:surgery*; D013519:Urogenital Surgical Procedures
D009539:Nicotinic Acids; D009525:Niacin; D010131:Aminosalicylic Acid; D013307:Streptomycin
CYSTITIS/etiology and pathogenesis; NICOTINIC ACID ISOMERS/therapeutic use; PARA-AMINOSALICYLIC ACID/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, UROGENITAL/surgery
L'avenir des tuberculoses urogénitales opérés.